MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about outcome of schedule of analyst meet

06 Aug 2024 Evaluate

Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that the recording is uploaded at https://indiapharma.gsk.com/en-in/investors/analyst-meets/.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..